YAP1 and small cell lung carcinoma: Conversely and interestingly, in a specific subset of small cell lung cancer cell lines and patients, the loss of YAP1 has been shown to be associated with an increase of neuroendocrine markers and a poorer prognosis [69,70] similar to what has been observed in haematologic malignancies.